Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

80%

4 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
4(80.0%)
N/A
1(20.0%)
5Total
Phase 4(4)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT00390065Phase 4Completed

Follow-Up at 6 Years of a Cohort of Children Born Very Prematurely

Role: lead

NCT02054507Not ApplicableCompleted

Prematurity Related Risks of Cognitive Impairment at School Age

Role: collaborator

NCT02279628Phase 4Unknown

Continuous Pre-uterine Wound Infiltration Versus Intrathecal Morphine for Postoperative Analgesia After Cesarean Section

Role: collaborator

NCT00389558Phase 4Completed

Antiseptic Use and Dressing Application

Role: lead

NCT00217191Phase 4Completed

Ibuprofen and Renal Function in Premature Infants

Role: lead

All 5 trials loaded